C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...

Today’s Cache | Elon Musk’s X sues Union Government; Nvidia to open quantum computing lab; Apple, Samsung make 94% of ...

Samsung has released footage showing the inside of its Galaxy Note 7 testing lab. The company recalled the smartphone and received 96% of the models after overheating, fires, and explosions.

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

The proof-of-concept showed, according to the corporations, how well artificial intelligence may raise network performance ...

Late last year, Samsung paired with Nvidia to carry out interoperability tests at Samsung Research's lab. The tests used ...